Exclusion of patients with brain metastases from cancer clinical trials

被引:20
|
作者
Patel, Roshal R. [1 ,2 ]
Verma, Vivek [1 ]
Miller, Austin B. [3 ]
Lin, Timothy A. [4 ]
Jethanandani, Amit [5 ]
Espinoza, Andres F. [6 ]
Mainwaring, Walker [6 ]
Augustyn, Alexander [1 ]
Fuller, C. David [1 ]
Sulman, Erik P. [7 ]
Yeboa, Debra N. [1 ]
Chung, Caroline C. [1 ]
McAleer, Mary Frances [1 ]
Li, Jing [1 ]
Yoshor, Daniel [6 ]
de Groot, John F. [1 ]
Mandel, Jacob J. [6 ]
Ludmir, Ethan B. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, 1400 Pressler St,Unit 1422, Houston, TX 77030 USA
[2] Albany Med Coll, Albany, NY 12208 USA
[3] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Houston, TX 77030 USA
[4] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[5] Univ Tennessee, Ctr Hlth Sci, Coll Med, Memphis, TN 38163 USA
[6] Baylor Coll Med, Houston, TX 77030 USA
[7] NYU, Langone Sch Med, New York, NY USA
关键词
D O I
10.1093/neuonc/noz246
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:577 / 579
页数:3
相关论文
共 50 条
  • [1] Exclusion of Patients With Brain Metastases in Published Phase III Clinical Trials for Advanced Breast Cancer
    Sharma, Alisha
    Searle, Karlee
    Hasan, Salwa
    Chan, Stephanie
    Pond, Gregory
    Jerzak, Katarzyna J.
    CLINICAL BREAST CANCER, 2022, 22 (07) : 629 - 633
  • [2] Clinical trials in melanoma patients with brain metastases
    Yushak, Melinda L.
    Chiang, Veronica L.
    Kluger, Harriet M.
    PIGMENT CELL & MELANOMA RESEARCH, 2015, 28 (06) : 741 - 743
  • [3] Exclusion of Gastrointestinal Cancer Patients With Prior Cancer From Clinical Trials: Is This Justified?
    Smyth, Elizabeth C.
    Tarazona, Noelia
    Peckitt, Clare
    Armstrong, Edward
    Mansukhani, Sonia
    Cunningham, David
    Chau, Ian
    CLINICAL COLORECTAL CANCER, 2016, 15 (02) : E53 - E59
  • [4] IMPACT OF RELAXING BRAIN METASTASES EXCLUSION CRITERIA ON COLON CANCER TRIALS POPULATION
    Li, Q.
    Wang, C.
    Chen, A.
    Li, Y.
    George, T. J.
    Bian, J.
    Guo, Y.
    VALUE IN HEALTH, 2023, 26 (06) : S377 - S377
  • [5] Exclusion of Male Patients in Breast Cancer Clinical Trials
    Duma, Narjust
    Hoversten, Katherine P.
    Ruddy, Kathryn J.
    JNCI CANCER SPECTRUM, 2018, 2 (02)
  • [6] Current state of clinical trials in breast cancer brain metastases
    Fares, Jawad
    Kanojia, Deepak
    Cordero, Alex
    Rashidi, Aida
    Miska, Jason
    Schwartz, Charles W.
    Savchuk, Solomiia
    Ahmed, Atique U.
    Balyasnikova, Irina V.
    Cristofanilli, Massimo
    Gradishar, William J.
    Lesniak, Maciej S.
    NEURO-ONCOLOGY PRACTICE, 2019, 6 (05) : 392 - 401
  • [7] Exclusion rates of patients living with HIV from cancer immunotherapy clinical trials.
    Vora, Kruti Bhagirath
    Awad, Mark M.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [8] Systemic therapy for lung cancer brain metastases: A rationale for clinical trials
    Oh, Yun
    Stewart, David J.
    ONCOLOGY-NEW YORK, 2008, 22 (02): : 168 - 178
  • [9] Clinical trials for breast cancer with brain metastases: Challenges and new directions
    Morikawa A.
    Jhaveri K.
    Seidman A.D.
    Current Breast Cancer Reports, 2013, 5 (4) : 293 - 301
  • [10] Diagnostic Clinical Trials in Breast Cancer Brain Metastases: Barriers and Innovations
    Fares, Jawad
    Kanojia, Deepak
    Rashidi, Aida
    Ahmed, Atique U.
    Balyasnikova, Irina, V
    Lesniak, Maciej S.
    CLINICAL BREAST CANCER, 2019, 19 (06) : 383 - 391